Ascendis Pharma
ASND
$108.56
Share price
-1.83%
Change (1 day)
-9.08%
Change (1 year)
Categories
Market capitalization of Ascendis Pharma (ASND)
Market cap: $6.25 Billion
As of March 2023 Ascendis Pharma has a market cap of $6.25 Billion. This makes Ascendis Pharma the world's 2030th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Ascendis Pharma from 2015 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $6.25 B | -10.21% |
| 2022 | $6.96 B | -8.98% |
| 2021 | $7.65 B | -14.11% |
| 2020 | $8.90 B | 33.45% |
| 2019 | $6.67 B | 152.89% |
| 2018 | $2.63 B | 81.2% |
| 2017 | $1.45 B | 122.15% |
| 2016 | $0.65 B | 42.45% |
| 2015 | $0.46 B |
End of Day market cap according to different sources
On Mar 29th, 2023 the market cap of Ascendis Pharma was reported to be:
$6.30 Billion
$6.32 Billion
$6.32 Billion
$6.33 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | $0.10 B | -98.32% | 🇺🇸 USA |
 Affimed
AFMD | $0.12 B | -98.08% | 🇩🇪 Germany |
 Advaxis ADXS | $6.21 M | -99.90% | 🇺🇸 USA |